PUBLISHER: QYResearch | PRODUCT CODE: 1386046
PUBLISHER: QYResearch | PRODUCT CODE: 1386046
The global Liver Disease Diagnostics market is projected to grow from US$ 13,361.64 million in 2023 to US$ 20,102.98 million by 2029, at a Compound Annual Growth Rate (CAGR) of 7.05% during the forecast period.
North America Liver Disease Diagnostics market size is valued at US$ 5,019.20 million in 2022, while Asia Pacific and Europe Liver Disease Diagnostics are US$ 3,036.97 million and US$ 3,690.05 million, severally. The proportion of the North America is 40.95% in 2022, while APAC and Europe are 24.78% and 30.11% respectively, and it is predicted that APAC proportion will reach 28.57% in 2029, trailing a CAGR of 8.99% through the analysis period. China, Japan, South Korea, and India are noteworthy markets in APAC. As for the Europe Liver Disease Diagnostics landscape, Germany is projected to reach US$ 1,292.90 million by 2029 trailing a CAGR of 6.06% during 2023-2029.
The global key companies of Liver Disease Diagnostics include: Roche, Abbott, Thermo Fisher Scientific, Siemens Healthineers, GE Healthcare, Canon Medical Systems, LabCorp, BD, Philips Healthcare and Randox Laboratories is the leading manufacturer in global Liver Disease Diagnostics market. The top 10 listed companies accounted for 39.41% of the market share in 2022 in terms of revenue.
This report presents an overview of global market for Liver Disease Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Liver Disease Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Liver Disease Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Liver Disease Diagnostics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Liver Disease Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Liver Disease Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott, Roche, Thermo Fisher Scientific, Randox Diagnostic Centers, Boston Scientific Corporation, LabCorp, Fujifilm Corporation, Horiba Medical, and Siemens Healthineers, etc.